Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:16 pm Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | ARMISTICE CAPITAL LLC | 3,357,953 9.990% | 1,593,953 (+90.36%) | View |
| 2024-11-14 4:15 pm Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Schonfeld Strategic Advisors LLC | 1,772,715 5.300% | 1,772,715 (New Position) | View |
| 2024-08-23 4:07 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | SAXENA PARAG | 6,251,606 16.900% | 6,251,606 (New Position) | View |
| 2024-08-23 4:06 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 2,893,914 8.600% | 8,236 (+0.29%) | View |
| 2024-08-14 4:07 pm Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | INTEGRATED CORE STRATEGIES (US) LLC | 1,563,595 5.200% | 1,563,595 (New Position) | View |
| 2024-05-31 9:30 pm Sale | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | VEDANTA PARTNERS LLC | 6,251,606 18.500% | -152,811 (-2.39%) | View |
| 2024-02-16 4:32 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 2,885,678 10.200% | 74,133 (+2.64%) | View |
| 2024-02-14 4:00 pm Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 3,098,615 9.990% | 832,386 (+36.73%) | View |
| 2024-02-14 3:52 pm Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | ARMISTICE CAPITAL LLC | 1,764,000 6.320% | 1,764,000 (New Position) | View |
| 2023-11-30 4:49 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | VEDANTA PARTNERS LLC | 6,404,417 19.900% | 339,243 (+5.59%) | View |
| 2023-05-05 4:30 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Bhat Laxminarayan | 2,811,545 13.500% | 332,689 (+13.42%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 2,266,229 9.990% | 916,049 (+67.85%) | View |
| 2022-09-12 4:35 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | VEDANTA PARTNERS LLC | 6,065,174 19.900% | 2,766,798 (+83.88%) | View |
| 2022-01-05 12:35 pm Sale | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | SABBY MANAGEMENT LLC | 0 0.000% | -904,710 (Position Closed) | View |
| 2021-06-11 6:07 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Nayar Rahul | 515,651 3.000% | 515,651 (New Position) | View |
| 2021-06-03 5:16 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | VEDANTA PARTNERS LLC | 3,298,376 18.100% | 3,298,376 (New Position) | View |
| 2021-06-03 08:30 am Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 1,350,180 9.990% | 1,350,180 (New Position) | View |
| 2021-01-19 5:19 pm Sale | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Tenzing LLC | 871,337 13.000% | -1,250,413 (-58.93%) | View |
| 2021-01-19 5:17 pm Sale | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Tenzing LLC | 2,121,750 22.980% | -540,500 (-20.30%) | View |
| 2021-01-19 5:15 pm Purchase | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Tenzing LLC | 2,662,250 27.240% | 2,662,250 (New Position) | View |